|
|
 |
|
Viewing report
|
|
|
|
Tinea Pedis (Athletes Foot) - Global Strategic Business Report
Global Industry Analysts, Inc., Aug 2010, Pages: 269
This report analyzes the US market for Tinea Pedis (Athletes Foot) in US$ Million. Annual estimates and forecasts are provided for the period of 2006 through 2015. The report profiles 43 companies including many key and niche players such as Hisamitsu Pharmaceutical Co., Inc., Johnson & Johnson, Kaken Pharmaceutical Co., Ltd., Merck & Co., Inc., Nitric BioTherapeutics, Inc., Novartis AG, Sanofi-Aventis, Stiefel Laboratories, Inc., and Topica Pharmaceuticals, Inc. Market data and analytics are derived from primary and secondary research. Company profiles are mostly extracted from URL research and reported select online sources.
Please note: Reports are sold as single-site single-user licenses. The delivery time for hard copies is between 3-5 business days, as each hard copy is custom printed for the organization ordering it. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks.
For information on site licence pricing please click on Enquire before buying
Customers who bought this item also bought
Tinea Pedis (Athlete's Foot) Therapy Area Pipeline Report
Tuberculosis Therapeutics - Global Strategic Business Report
Veterinary Vaccines - Global Strategic Business Report
Multiple Myeloma Therapeutics - Global Strategic Business Report
Drug-Eluting Stents - Global Strategic Business Report
Hepatitis C Virus and Therapeutics - Global Strategic Business Report
Wound Care Products - Global Strategic Business Report
Hormone Replacement Therapy (HRT) - Global Strategic Business Report
Alzheimers and Parkinsons Disease - Global Strategic Business Report
Multiple Sclerosis Therapeutics - Global Strategic Business Report
|
|
|
|
